Dermatology Doctors in Anchorage, AK Accepting Medicare

13 Dermatology doctors found. Showing 1 - 13

Stephanie Ann Mcleish, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St Ste T4-020, Anchorage, AK 99508 Phone: 907-646-8500

Dr. Andrzej R Maciejewski, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3260 Providence Dr, #523, Anchorage, AK 99508 Phone: 907-569-1049    Fax: 907-563-4564

Dr. Courtney Weathersby Bagayoko, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 615 E 82nd Ave Ste 204, Anchorage, AK 99518 Phone: 907-865-8455    Fax: 913-246-4901

Gina M Brown, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3340 Providence Dr Ste A358, Anchorage, AK 99508 Phone: 907-268-2067    Fax: 855-395-0858

Thomas P Senter, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 636 Barrow St, Anchorage, AK 99501 Phone: 907-276-1315    Fax: 907-278-7129

Jeffrey Joseph Bidinger, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St Ste T4-020, Anchorage, AK 99508 Phone: 907-646-8500    Fax: 907-646-9760

Michael D Michener, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St Ste T4-020, Anchorage, AK 99508 Phone: 907-646-8500    Fax: 907-646-9760

Peter George Ehrnstrom, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper Street, Suite T4-020, Anchorage, AK 99508 Phone: 907-646-8500    Fax: 907-646-9760

Robert Franklin Moreland Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St Ste T4-020, Anchorage, AK 99508 Phone: 907-646-8500    Fax: 907-646-9760

Margretta Ann O'reilly, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3841 Piper Street, Suite T4-020, Anchorage, AK 99508 Phone: 907-646-8500    Fax: 907-646-9760

Dr. Janine D'amelio Miller, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 915 W Northern Lights Blvd, Anchorage, AK 99503 Phone: 907-770-6700    Fax: 907-865-5908

Dr. Jayne S Fortson, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2401 E 42nd Ave, Ste 301, Anchorage, AK 99508 Phone: 907-563-3204    Fax: 907-563-4283

John Schultz, D.O. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 8501 Sultana Dr, Anchorage, AK 99516 Phone: 907-345-4076    Fax: 907-345-4076

News Archive

Taskforce formed to help speed licensure, vaccine distribution following RTS,S trials

GNA/Peace FM examines the recent creation of a local and international taskforce to help shorten the window of time between the completion of the clinical trial of the RTS,S malaria vaccine - currently being tested across Africa - and licensure and vaccine distribution. According to the news service, scientists recently launched a Phase III trial of the RTS,S vaccine in Kintampo, Ghana, which will include 1,200 children, between the ages of 6-12 weeks and 5-17 months.

Researchers encourage more caution in use of ADHD medicine

Authors of new Cochrane Review remain uncertain about effect of widely used medicine on ADHD symptoms, despite large amount of research. Some evidence of increased sleeplessness and loss of appetite leads researchers to encourage more caution in use of methylphenidate.

Emergent in active discussions with U.S. government for multi-year supply of BioThrax to the SNS

Emergent BioSolutions Inc. today announced that the U.S. government has indicated its intention to award Emergent a sole source contract (RFP-2011-N-13414) for the purchase of 44.75 million doses of BioThrax (Anthrax Vaccine Adsorbed) for inclusion in the Strategic National Stockpile (SNS) over a 5 year period.

Selenium secures NIH grant to apply patented antimicrobial technology for ear infections

Selenium, Ltd., a biopharmaceutical company focused on unique solutions to meet antimicrobial coating and therapeutic needs, has been awarded a research grant from the National Institute on Deafness and Other Communication Disorders, one of the National Institutes of Health. With the $155,387 NIH grant the company will apply its proprietary antimicrobial technology to researching the inhibition of biofilms on tympanostomy tubes.

Read more Medical News

› Verified 8 days ago